Literature DB >> 2296621

Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.

P M Callahan1, J B Appel.   

Abstract

The discriminative stimulus properties of (+)-lysergic acid diethylamide (LSD) and lisuride hydrogen maleate (LHM), were compared in a three-choice, water reinforced (FR 20) situation in which rats were required to press one lever following LSD (0.08 mg/kg), a second lever following LHM (0.04 mg/kg), and a third lever following saline. Reliable drug-appropriate responding was established in 72 sessions. Dose-response tests with LSD and LHM indicated that, as dose increased, the per cent of responding on the lever associated with the particular training drug also increased; little or no cross-transfer occurred between LSD and LHM. In generalization tests, the serotonin (5-HT) agonist quipazine substituted for LSD but not LHM while the dopamine (DA) agonist apomorphine mimicked LHM but not LSD; an unrelated compound, pentylenetetrazol (PTZ), produced responding on the saline-appropriate lever. In combination tests, 5-HT antagonists (e.g., BC-105 and low doses of pirenperone) blocked responding on the LSD lever while DA antagonists (e.g., haloperidol and much higher doses of pirenperone) blocked LHM-appropriate responding. These data suggest that the three-lever (D-D-N) procedure is similar to, but can be more sensitive than the two-lever (D-N) procedure (because it can differentiate between LSD and LHM); they therefore at least partially support the hypothesis that three-choice discriminations can be conceptualized as two separate, two-choice (D-N) discriminations (Jarbe and Swedberg 1982). The results also confirm suggestion that the stimulus effects of LSD and LHM are mediated by different mechanisms; the primary action of LSD is serotonergic (5-HT2), while that of LHM is dopaminergic (White 1986).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296621     DOI: 10.1007/bf02245782

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  The legacy of Guttman and Kalish (1956): Twenty-five years of research on stimulus generalization.

Authors:  W K Honig; P J Urcuioli
Journal:  J Exp Anal Behav       Date:  1981-11       Impact factor: 2.468

2.  Drug discrimination procedures: roles of relative stimulus control in two-drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.

Authors:  C P France; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

4.  Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.

Authors:  J B Appel; F J White; A M Holohean
Journal:  Neurosci Biobehav Rev       Date:  1982       Impact factor: 8.989

5.  Drug discrimination and generalization in pigeons.

Authors:  M R Leberer; S C Fowler
Journal:  Pharmacol Biochem Behav       Date:  1977-11       Impact factor: 3.533

6.  Discriminative stimulus properties of lisuride revisited: involvement of dopamine D2 receptors.

Authors:  K A Cunningham; P M Callahan; J B Appel
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

7.  Discriminative stimulus properties of lergotrile.

Authors:  K A Cunningham; P M Callahan; J B Appel
Journal:  J Pharmacol Exp Ther       Date:  1984-07       Impact factor: 4.030

8.  Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.

Authors:  F J White; J B Appel
Journal:  Science       Date:  1982-04-30       Impact factor: 47.728

9.  Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.

Authors:  F J White
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

10.  Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.

Authors:  J M White; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  6 in total

Review 1.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

2.  Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

Authors:  Mario de la Fuente Revenga; Urjita H Shah; Nima Nassehi; Alaina M Jaster; Prithvi Hemanth; Salvador Sierra; Malgorzata Dukat; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2021-01-05       Impact factor: 4.418

3.  Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Authors:  Danuta Marona-Lewicka; Ronald A Thisted; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2005-02-19       Impact factor: 4.530

4.  Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task.

Authors:  Kaili Jiang; Xiaoyan Liu; Ruibin Su
Journal:  Psychopharmacology (Berl)       Date:  2022-09-15       Impact factor: 4.415

5.  Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Authors:  Bruce E Blough; Antonio Landavazo; Ann M Decker; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

Review 6.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.